Drug Trial Radar · NCT02981836
A Blind, Randomized and Controlled Study of Live Attenuated Varicella Vaccines
Last checked: Nov 20, 2026Latest source record: Oct 26, 2017 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
5,997
Actual
Start
Aug 2016
Primary completion
Jun 2017
Study completion Sep 2017
Sponsor
- Lead sponsor
- Sinovac (Dalian) Vaccine Technology Co., Ltd.Industry
- Sponsor type
- Industry
- First posted
- Dec 5, 2016
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, investigator, outcomes assessor)
- Primary purpose
- Prevention
- Who can join
- All sexes, from 1 year, up to 12 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the protective effect, safety and immunogenicity of a live attenuated varicella vaccine in healthy children.
Conditions
- Varicella
Interventions
Investigational live attenuated varicella vaccineBiological
The investigational vaccine was manufactured by Sinovac (Dalian) Vaccine Technology Co., Ltd.
diluent of lyophilized vaccineBiological
The diluent of lyophilized vaccine was manufactured by Sinovac (Dalian) Vaccine Technology Co., Ltd.
Primary outcomes
What the sponsor says the trial is designed to measure.
- The incidences of varicella of each groupTime frame: ≥30 cases reported 30 days after injection
- The protection rate of the vaccineTime frame: ≥30 cases reported after 30 days of the injection
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
Xiangcheng County Center for Disease Control and Prevention
Xuchang, Henan, China
Biyang County Center for Disease Control and Prevention
Zhumadian, Henan, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.